3 stories mentioning LYELUpdated 8d ago
Every FINWIRES story that references LYEL, newest first.
Lyell Immunopharma (LYEL) has an average rating of overweight and mean price target of $38.14, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Lyell Immunopharma (LYEL) has an average rating of buy and mean price target of $42.20, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
